Emergent BioSolutions Inc. cotiza a 6.94 USD y tiene una capitalización bursátil de $356M. En los últimos 12 meses ha facturado $770M con un margen de flujo de caja libre del 21.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The compa…
| Métrica | EBS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 56.1% | 57.0% | -0.9% |
| Operating Margin | 13.5% | -38.6% | +52.1% |
| Net Margin | 7.1% | -33.6% | +40.6% |
| FCF Margin | 21.1% | -13.9% | +35.0% |
| ROE | 10.1% | -40.4% | +50.5% |
| ROA | 4.0% | -32.0% | +36.0% |
| Current Ratio | 5.01 | 2.84 | +2.17 |
| Debt / Equity | 1.13 | 0.28 | +0.85 |